Intuitive Surgical (ISRG) continues to dominate the surgical robotics market, with its da Vinci systems driving a 500% stock increase over the past decade. However, the company trades at a high price-to-earnings ratio of 55x, raising concerns among investors, especially as it experiences a 20% pullback from its recent peak. Notably, only 24% of its revenue comes from new system sales, with the majority generated from parts and services, highlighting the strength of its recurring revenue model.
In contrast, Medtronic (MDT) is entering the surgical robotics arena with its new Hugo robot, aiming to capitalize on the growing demand for robotic-assisted surgeries. Despite a 40% decline from its 2021 high, Medtronic offers a more attractive P/E ratio of 22x and a dividend yield of 3.6%, appealing to conservative investors seeking stability and income.
For market professionals, Medtronic presents a compelling alternative to Intuitive Surgical, particularly for those prioritizing diversification and consistent returns amid market volatility.
Source: fool.com